West Explain current approaches to the treatment of NASH and NAFLD Session I: Portal Hypertension: Global Perspective 8:00 – 8:05 AM Introduction Thomas D. Boyer, MD 8:05 – 8:25 AM Portal Hypertension in Schistosomiasis: Management Alberto Q. Farias, MD, PhD 8:25 – 8:45 AM Huge Spleens and Hypersplenism: Observe, Embolize or Remove Thomas D. Boyer, MD 8:45 – 9:05 AM Management of Budd-Chiari Syndrome Juan Carlos Garcia-Pagan, MD 9:05 – 9:25 AM Management of Portal Vein Thrombosis: With and Without Cirrhosis Dominique R428 Valla, MD 9:25 – 9:45 AM Idiopathic Portal Hypertension: Diagnosis

and Management Shiv K. Sarin, MD 9:45 – 10:05 AM Panel Discussion and Questions 10:05 -10:25 AM Break Session II: NAFLD/NASH: Global Perspective 10:25 – 10:30 AM Introduction K. Rajender Reddy, MD 10:30 – 10:50 AM Global Epidemiology of NAFLD/NASH Jeanne M. Clark, MD 10:50 -11:10 AM Pathogenesis of NASH – Geographical Differences

Jian-Gao Fan, MD,PhD 11:10 – 11:30 AM Gender, Racial and Ethnic Differences in NAFLD/NASH selleck chemicals llc Elizabeth E. Powell, MD 11:30 -11:50 AM NAFLD/NASH Presentation in the East vs. West Deepak N. Amarapurkar, MD 11:50 AM -12:10 PM Therapy of NAFLD/NASH Arun J. Sanyal, MD 12:10 – 12:30 PM Panel Discussion and Questions AASLD/ILTS Transplant Course Friday, November 1 Dapagliflozin 8:00 AM – 3:30 PM Room 146BC Liver Transplantation – First Quarter, Second Decade COURSE DIRECTORS: John R. Lake, MD John O’Grady 7.5 CME Credits / 6 Contact Hours The overall goals of the course are to enhance understanding of

up-to-date integrated care of the graft and patient during the first three months and to determine if management strategies should change with extended survival. The course will initially take a focused view of the first three months after liver transplantation which remains the time period of highest risk to graft and patient. This section will deal with: The critical definition of the role of intensive care after liver transplantation The management of specific complications subject to evolving attitudes to management The re-evaluation of diagnostic paradigms for common but non-specific patterns of graft dysfunction The second part of the course will address the issue of survival into the second decade after transplantations and beyond. This is in response to the rapidly increasing number of patients entering this phase and the lack of attention this had received in educational symposia.